Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology
Biomedical Science Letters · 30.09.2022 · 28 (3) · 145-156
DOI: 10.15616/bsl.2022.28.3.145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Science Letters, erschienen am 30.09.2022. Verfasst von Kyeong Seob Shin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Over the past few decades, few technologies have had a greater impact on clinical microbiology laboratories than matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS).The MALDI-TOF MS is a fast, accurate, and low-cost and efficient method of microbial identification.This technology generates characteristic mass spectral fingerprints that is a unique signature for each microorganism, making it an ideal method for accurate identification at the genus and species levels of both bacterial and fastidious microorganism such as anaerobes, mycobacterium and fungi etc.In addition, MALDI-TOF MS has been successfully used in microbial subtyping and susceptibility tests such as determination of resistance genes.In this study, the authors summarized the application of MALDI-TOF MS in clinical microbiology and clinical research and explored the future of MALDI-TOF MS.
Zitieren
APA
Shin, K. S., & Yum, J. (2022). Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology. Biomedical Science Letters, 28(3), 145-156. https://doi.org/10.15616/bsl.2022.28.3.145
Vancouver
Shin KS, Yum J. Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology. Biomedical Science Letters. 2022;28(3):145-156. doi:10.15616/bsl.2022.28.3.145
BibTeX
@article{Shin2022,
author = {Shin, Kyeong Seob and Yum, Jonghwa},
title = {Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology},
journal = {Biomedical Science Letters},
year = {2022},
volume = {28},
number = {3},
pages = {145--156},
doi = {10.15616/bsl.2022.28.3.145}
}
EUVIMED